IVUS Catheters Market Report (2023 to 2031) – Abbott, GE HealthCare, Medtronic plc, ICU Medical Inc., and Boston Scientific Corporation
Growth Plus Reports
6 min read
Growth Plus Reports
Newark, New Castle, USA, June 20, 2023 (GLOBE NEWSWIRE) -- According to the most recent study by Growth Plus Reports, the global IVUS catheters market was valued at US$ 627.1 million and is expected to rise at a revenue CAGR of 6.9% to reach US$ 1,143.1 million by 2031.
The global market for IVUS catheters was analyzed, and it is expected to rise significantly during the forecast period. Intravascular ultrasound (IVUS) catheters analyze blood vessel tissue by introducing a tiny tube into the blood vessel to discover and treat cardiovascular disorders by collecting clear pictures internally from blood vessels.
Recent Development in the Global IVUS Catheters Market:
In February 2023, the US FDA granted Northeast Scientific Inc. 510(k) certification for the reprocessed Philips IVUS Eagle Eye Platinum RX Digital catheter.
In July 2022, intravascular Imaging Inc. launched the 3 Fr NIRF-IVUS imaging equipment for human coronary imaging.
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Key Takeaways:
Growing demand for the non-invasive and precise diagnostic method drives the market revenue share.
The early detection of heart conditions for effective treatment is driving the demand for IVUS catheters.
Several advancements and increasing R&D activities are creating a strong product pipeline.
Market Drivers and Restraints:
The driving factor for the IVUS catheters market revenue is its accuracy, safety, and growing need for non-invasive procedures. Furthermore, IVUS catheters offer enhanced accuracy, minimal invasiveness, and real-time monitoring, contributing to market revenue growth.
However, reusing disposable IVUS catheters and rising prices to endanger patient safety are expected to restrain market revenue growth.
Based on modality, the global IVUS catheters market is segmented into virtual histology IVUS, iMap IVUS, and integrated backscatter IVUS. Due to the change in caliber and a better understanding of intravascular ultrasound imaging, the virtual histology IVUS segment accounts for the largest market revenue share.
Segmentation By Type
Based on type, the global IVUS catheter market is segmented into mechanical IVUS catheters, solid-state IVUS catheters, digital IVUS catheters, and others. The mechanical IVUS catheters segment accounts for the largest market revenue share due to the small transducers, enabling critical procedures and real-time imaging during catheterization procedures.
Segmentation By Indication
Based on indication, the global IVUS catheters market is segmented into aortic aneurysms, blood clots, coronary artery diseases, and deep vein thrombosis. The coronary artery disease segment accounts for the largest market revenue share due to its rising prevalence, consequences for death and disability, and enormous financial burden.
Segmentation By End-User
Based on the end-user, the global IVUS catheters market is segmented into hospitals, ambulatory surgical centers, diagnostic imaging centers, and others. The hospital segment accounts for the largest revenue share as angiography, electrophysiological testing, and other catheter-based procedures used to identify cardiovascular disorders are often performed in hospitals.
Regional Growth Dynamics
Based on the region, the global IVUS catheters market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to chronic disease prevalence, high healthcare costs, and modern healthcare infrastructure, North America accounts for the largest revenue share in the global market.
Competitive Landscape
Following is a list of the top market players operating in the global market for IVUS catheters:
Cordis
GE HealthCare
Abbott
ACIST Medical Systems
Boston Scientific Corporation
Cook Medical
Report Coverage
Growth Plus Reports studied the global market for IVUS catheters in-depth and analyzed the basic market characteristics, significant investment areas, analytics of regional growth, revenue forecast, competitive market players, mergers, and acquisitions.
Table of Content
INTRODUCTION
Market Ecosystem
Timeline Under Consideration
Historical Years – 2021
Base Year – 2022
Forecast Years – 2023 to 2031
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Data Collection Methodology
Data Sources
Secondary Sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecasting Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trends (COVID-19 Perspective)
Key Players & Competitive Positioning (2022)
Regulatory Landscape
Reimbursement Scenario
MARKET DYNAMICS
Drivers
Restraints/Challenges
Opportunities
GLOBAL IVUS CATHETERS MARKET - ANALYSIS & FORECAST, BY MODALITY
Virtual Histology IVUS
iMap IVUS
Integrated Backscatter IVUS
GLOBAL IVUS CATHETERS MARKET - ANALYSIS & FORECAST, BY TYPE
Mechanical IVUS Catheters
Solid-state IVUS Catheters
Digital IVUS Catheters
Others
GLOBAL IVUS CATHETERS MARKET - ANALYSIS & FORECAST, BY INDICATION
Sympathomimetic Drugs Market by Type (Direct, Indirect, Mized), Indications (Cardiovascular Diseases, Asthma & COPD), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Cortisone Acetate Market by Indication (Rheumatic Diseases, Dermatologic Conditions), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Belladonna Alkaloids Market by Type (Atropine, Hyoscyamine), Application (Gastrointestinal Disorders, Respiratory Disorders, Overactive Bladder), Route of Administration (Oral, Topical), End User (Hospitals, Pharmaceutical Companies)-Global Outlook & Forecast 2023-2031
Calcium Homeostasis Drugs Market by Drug Class (Calcium Metabolism Modifiers, Parathyroid Hormone Analogs), Indication (Hypocalcemia, Hypercalcemia), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Mirvetuximab Soravtansine Market by Indication (Ovarian Cancer, Fallopian Tube Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
